A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia Read more about A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome Read more about Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy Read more about Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
Benfotiamine in Alzheimer's Disease: A Pilot Study Read more about Benfotiamine in Alzheimer's Disease: A Pilot Study
Phase I/II Study of Avelumab in Pediatric Cancer Subjects Read more about Phase I/II Study of Avelumab in Pediatric Cancer Subjects
Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy Read more about Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects Read more about Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects
Greater Occipital Nerve Block Versus Metoclopramide Read more about Greater Occipital Nerve Block Versus Metoclopramide
Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome Read more about Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome